---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-018094"
form_type: "8-K"
ticker: "ALXO"
cik: "0001810182"
company_name: "ALX ONCOLOGY HOLDINGS INC"
filed_at: "2026-01-21T23:59:59+00:00"
generated_at: "2026-05-16T09:20:16.228298+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ALX Oncology increases inducement plan share reserve by 1.3M shares to total 2.8M shares

## Summary
- Board amended 2025 Inducement Equity Incentive Plan to reserve an additional 1,300,000 shares of common stock.
- Total shares reserved under the inducement plan now 2,800,000.
- Amendment adopted without stockholder approval per Nasdaq inducement award exception rules.
- Awards under the plan will be granted only to new employees as material inducement to join the Company.
- Plan terms are substantially similar to the Amended and Restated 2020 Equity Incentive Plan.

## SEC filing metadata
- accession: 0001193125-26-018094
- form_type: 8-K
- ticker: ALXO
- cik: 0001810182
- company_name: ALX ONCOLOGY HOLDINGS INC
- filed_at: 2026-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/0001193125-26-018094-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810182/000119312526018094/alxo-20260121.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-018094
- JSON: https://secwatch.observer/filing/0001193125-26-018094.json
- Plain text: https://secwatch.observer/filing/0001193125-26-018094.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.